Two Sigma Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$268K Sell
8,500
-24,800
-74% -$782K ﹤0.01% 2006
2025
Q1
$1.09M Buy
33,300
+25,500
+327% +$835K ﹤0.01% 1436
2024
Q4
$282K Buy
7,800
+1,000
+15% +$36.2K ﹤0.01% 2003
2024
Q3
$212K Sell
6,800
-23,800
-78% -$742K ﹤0.01% 2043
2024
Q2
$819K Sell
30,600
-112,700
-79% -$3.01M ﹤0.01% 1655
2024
Q1
$4.89M Sell
143,300
-83,800
-37% -$2.86M 0.01% 789
2023
Q4
$6.57M Buy
227,100
+31,000
+16% +$897K 0.02% 694
2023
Q3
$5.41M Sell
196,100
-83,300
-30% -$2.3M 0.01% 692
2023
Q2
$8.4M Sell
279,400
-30,300
-10% -$911K 0.02% 564
2023
Q1
$11.2M Buy
309,700
+93,700
+43% +$3.39M 0.03% 520
2022
Q4
$7.7M Buy
216,000
+118,700
+122% +$4.23M 0.02% 595
2022
Q3
$3.29M Buy
97,300
+83,000
+580% +$2.81M 0.01% 937
2022
Q2
$414K Sell
14,300
-16,400
-53% -$475K ﹤0.01% 2003
2022
Q1
$992K Buy
30,700
+8,400
+38% +$271K ﹤0.01% 1642
2021
Q4
$650K Buy
22,300
+9,500
+74% +$277K ﹤0.01% 1778
2021
Q3
$341K Sell
12,800
-74,000
-85% -$1.97M ﹤0.01% 2064
2021
Q2
$2.67M Sell
86,800
-146,000
-63% -$4.5M 0.01% 1158
2021
Q1
$6.1M Buy
232,800
+89,600
+63% +$2.35M 0.02% 768
2020
Q4
$3.6M Sell
143,200
-99,500
-41% -$2.5M 0.01% 960
2020
Q3
$5.06M Sell
242,700
-173,500
-42% -$3.62M 0.01% 764
2020
Q2
$9.89M Buy
416,200
+36,400
+10% +$865K 0.03% 560
2020
Q1
$6.83M Buy
379,800
+250,200
+193% +$4.5M 0.03% 612
2019
Q4
$3.07M Sell
129,600
-300
-0.2% -$7.12K 0.01% 1032
2019
Q3
$3.57M Sell
129,900
-199,300
-61% -$5.48M 0.01% 891
2019
Q2
$10.9M Buy
329,200
+97,000
+42% +$3.21M 0.03% 560
2019
Q1
$8.14M Buy
+232,200
New +$8.14M 0.02% 669
2018
Q3
Sell
-11,600
Closed -$694K 2389
2018
Q2
$694K Buy
11,600
+4,600
+66% +$275K ﹤0.01% 1782
2018
Q1
$321K Buy
+7,000
New +$321K ﹤0.01% 1982
2017
Q3
Sell
-18,400
Closed -$793K 2345
2017
Q2
$793K Buy
18,400
+200
+1% +$8.62K ﹤0.01% 1625
2017
Q1
$570K Buy
18,200
+300
+2% +$9.4K ﹤0.01% 1837
2016
Q4
$452K Buy
17,900
+1,700
+10% +$42.9K ﹤0.01% 1922
2016
Q3
$401K Buy
+16,200
New +$401K ﹤0.01% 1768
2015
Q2
Sell
-36,600
Closed -$442K 2059
2015
Q1
$442K Buy
+36,600
New +$442K ﹤0.01% 1406